The prognostic value of p27 in gastric cancer

Oncology

Volumn 63, Issue 2, 2002, Pages 180-184

  Wiksten, Jan Patrik ^a   Lundin, Johan ^a   Nordling, Stig ^a   Kokkola, Arto ^a   Von Boguslawski, Kristina ^a   Haglund, Caj ^a,b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Gastric cancer; Immunohistochemistry; p27; Prognosis

Indexed keywords

MONOCLONAL ANTIBODY; PARAFFIN; PROTEIN ANTIBODY; PROTEIN P27;

ADULT; AGE; AGED; ARTICLE; CANCER CELL; CANCER GRADING; CANCER INVASION; CANCER LOCALIZATION; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DEPLETION; PROTEIN EXPRESSION; SEX DIFFERENCE; STOMACH CARCINOMA; STOMACH SURGERY; TUMOR DIFFERENTIATION;

AGED; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; FEMALE; FOLLOW-UP STUDIES; GASTRIC MUCOSA; GENES, TUMOR SUPPRESSOR; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TIME FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 0036381456     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000063813     Document Type: Article

References (17)

1. Toyoshima H, Hunter T: p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 1994;78(1):67-74.
2. Pagano M, Tam SW, Theodoras AM, Beer-Romero P, Del Sal G, Chau V, Yew PR, Draetta GF, Rolfe M: Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 1995;269(5224):682-685.
3. Leivonen M, Nordling S, Lundin J, von Boguslawski K, Haglund C: p27 expression correlates with short-term, but not with long-term prognosis in breast cancer. Breast Cancer Res Treat 2001;67(1):15-22.
4. Tenjo T, Toyoda M, Okuda J, Watanabe I, Yamamoto T, Tanaka K, Ohtani M, Nohara T, Kawasaki H, Tanigawa N: Prognostic significance of p27(kip1) protein expression and spontaneous apoptosis in patients with colorectal adenocarcinomas. Oncology 2000;58(1):45-51.
5. Shamma A, Doki Y, Tsujinaka T, Shiozaki H, Inoue M, Yano M, Kawanishi K, Monden M: Loss of p27(KIP1) expression predicts poor prognosis in patients with esophageal squamous cell carcinoma. Oncology 2000;58(2):152-158.
6. Kim DH, Lee HI, Nam ES, Shin HS, Sohn JH, Park CH, Yoon DS, Song SY, Park Y: Reduced expression of the cell-cycle inhibitor p27Kip1 is associated with progression and lymph node metastasis of gastric carcinoma. Histopathology 2000;36(3):245-251.
7. Ohtani M, Isozaki H, Fujii K, Nomura E, Niki M, Mabuchi H, Nishiguchi K, Toyoda M, Ishibashi T, Tanigawa N: Impact of the expression of cyclin-dependent kinase inhibitor p27Kip1 and apoptosis in tumor cells on the overall survival of patients with non-early stage gastric carcinoma. Cancer 1999;85(8):1711-1718.
8. Kwon OJ, Kang HS, Suh JS, Chang MS, Jang JJ, Chung JK: The loss of p27 protein has an independent prognostic significance in gastric cancer. Anticancer Res 1999;19(5B):4215-4220.
9. Sgambato A, Migaldi M, Leocata P, Ventura L, Criscuolo M, Di Giacomo C, Capelli G, Cittadini A, De Gaetani C: Loss of p27Kip1 expression is a strong independent prognostic factor of reduced survival in N0 gastric carcinomas. Cancer 2000;89(11):2247-2257.
10. Muller W, Grabsch H, Takeno S, Noguchi T, Hommel G, Gabbert HE: Prognostic value of the cyclin-dependent kinase inhibitor p27Kip1 in gastric cancer. Anticancer Res 2000;20(3A):1787-1792.
11. Feakins RM, Mulcahy HE, Quaglia A, Jawhari A, Zhang Z, Patchett SE: p27(Kip1) loss does not predict survival in patients with advanced gastric carcinoma. Cancer 2000;89(8):1684-1691.
12. Hermanek P, Sobin LH: TNM classification of malignant tumours. Fourth Edition, 2nd Revision. Berlin: Springer-Verlag, 1992:45-48.
13. Itami A, Shimada Y, Watanabe G, Imamura M: Prognostic value of p27(Kip1) and CyclinD1 expression in esophageal cancer. Oncology 1999;57(4):311-317.
14. Ponce-Castaneda MV, Lee MH, Latres E, Polyak K, Lacombe L, Montgomery K, Mathew S, Krauter K, Sheinfeld J, Massague J, et al: p27Kip1: chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors. Cancer Res 1995;55(6):1211-1214.
15. Steele RJ, Chung SC, Li AK, Crofts TJ: Hepatic metastases in Hong Kong Chinese: evidence for an East-West difference in gastric cancer. Ann R Coll Surg Engl 1987;69(2):61-63.
16. Huang JQ, Sridhar S, Chen Y, Hunt RH: Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 1998;114(6):1169-1179.
17. Shirin H, Sordillo EM, Kolevska TK, Hibshoosh H, Kawabata Y, Oh SH, Kuebler JF, Delohery T, Weghorst CM, Weinstein IB, Moss SF: Chronic Helicobacter pylori infection induces an apoptosis-resistant phenotype associated with decreased expression of p27(kip1). Infect Immun 2000;68(9):5321-5328.